Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments. | Cell Rep Med | 2021 | 34467250 | PubTator, text mining | PubMed |
| Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19. | Elife | 2021 | 34463615 | PubTator, text mining | PubMed |
| Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. | Transplant Cell Ther | 2021 | 34461278 | PubTator, text mining | PubMed |
| Effect of SYTL3-SLC22A3 Variants, Their Haplotypes, and G × E Interactions on Serum Lipid Levels and the Risk of Coronary Artery Disease and Ischaemic Stroke. | Front Cardiovasc Med | 2021 | 34458338 | PubTator, text mining | PubMed |
| Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK. | Proc Natl Acad Sci U S A | 2021 | 34452995 | PubTator, text mining | PubMed |
| Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus. | Front Med (Lausanne) | 2021 | 34447768 | PubTator, text mining | PubMed |
| Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. | Front Immunol | 2021 | 34447369 | PubTator, text mining | PubMed |
| Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases. | Molecules | 2021 | 34443496 | PubTator, text mining | PubMed |
| Non-Covalent BTK Inhibitors-The New BTKids on the Block for B-Cell Malignancies. | J Pers Med | 2021 | 34442408 | PubTator, text mining | PubMed |
| Genes Common in Primary Immunodeficiencies and Cancer Display Overrepresentation of Codon CTG and Dominant Role of Selection Pressure in Shaping Codon Usage. | Biomedicines | 2021 | 34440205 | PubTator, text mining | PubMed |
| Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network. | Cancers (Basel) | 2021 | 34439388 | PubTator, text mining | PubMed |
| Application of Single Nucleotide Polymorphism Microarray in Prenatal Diagnosis of Fetuses with Central Nervous System Abnormalities. | Int J Gen Med | 2021 | 34393503 | PubTator, text mining | PubMed |
| IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells. | Front Immunol | 2021 | 34386002 | PubTator, text mining | PubMed |
| Targeting ITK signaling for T cell-mediated diseases. | iScience | 2021 | 34368657 | PubTator, text mining | PubMed |
| SYTL3-SLC22A3 Single-Nucleotide Polymorphisms and Gene-Gene/Environment Interactions on the Risk of Hyperlipidemia. | Front Genet | 2021 | 34367243 | PubTator, text mining | PubMed |
| Human inborn errors of immunity to oncogenic viruses. | Curr Opin Immunol | 2021 | 34364035 | PubTator, text mining | PubMed |
| Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors. | Front Immunol | 2021 | 34349760 | PubTator, text mining | PubMed |
| Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review. | Metabol Open | 2021 | 34345815 | PubTator, text mining | PubMed |
| Epidemiological investigation of hemophagocytic lymphohistiocytosis in China. | Orphanet J Rare Dis | 2021 | 34344437 | PubTator, text mining | PubMed |
| Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity. | Front Immunol | 2021 | 34335585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=44